Ezetimibe (Zetia): a new type of lipid-lowering agent
- PMID: 16278712
- PMCID: PMC1200795
- DOI: 10.1080/08998280.2003.11927928
Ezetimibe (Zetia): a new type of lipid-lowering agent
References
-
- Talbert R. Hyperlipidemia. In: Dipiro J, Talbert R, editors. Pharmacothempy: A Pathophysiologic Approach. 5th ed. Stanford, Conn: Appleton & Lange; 2002. pp. 395–396.
-
- Drug Facts and Comparisons. St. Louis: Facts and Comparisons, April 2003: 548b.
-
- Zetia® (ezetimibe) tablets [product information] North Wales, Pa: Merck/Schering-Plough; October 2002.
-
- Dujovne CA, Ettinger MP, McNeer JF, Lipka LJ, LeBeaut AP, Suresh R, Yang B, Veltri EP. Efficacy and safety of a potent new selective cholesterol absorp tion inhibitor, ezetimibe, in patients with primary hypercholesterolemia. Am J Cardiol. 2002;90:1092–1097. - PubMed
-
- Gagne C, Gaudet D, Bruckert E. Efficacy and safety of ezetimibe coadmin-istered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation. 2002;105:2469–2475. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources